Indicated for: schizophrenia; bipolar disorder
Route of administration: oral
Substance: amisulpride (antipsychotic)
ATC: N05AL05 (Nervous system | Antipsychotics | Benzamides)
Amisulpride is an atypical antipsychotic primarily used for the treatment of schizophrenia and other psychotic disorders. It works by blocking dopamine D2 and D3 receptors, helping to reduce positive symptoms (such as hallucinations and delusions) and negative symptoms (such as social withdrawal and lack of motivation) associated with schizophrenia.
Amisulpride is administered orally, usually once or twice daily, with the dosage adjusted based on the severity of symptoms and the patient's response to treatment.
Common side effects include weight gain, drowsiness, dizziness, gastrointestinal disturbances, and increased prolactin levels, which may lead to galactorrhea or amenorrhea. In rare cases, severe adverse reactions such as neuroleptic malignant syndrome or extrapyramidal disorders may occur.
Patients taking amisulpride should undergo regular monitoring for signs of adverse reactions and treatment efficacy. Additionally, the medication may interact with other drugs, such as antidepressants or sedatives, requiring caution. Amisulpride is an effective option for managing schizophrenia, but its use must be carefully supervised by a specialist physician.